Johnson and Johnson has declared yet another Tylenol recall of drugs created by McNeil Consumer Healthcare, one of its subsidiaries. The latest Tylenol recall is the 5th such action in 12 months for the pharmaceutical giant. The litany of product defects has brought the attention of Congress, which has put the company’s quality control practices under investigation. The latest Tylenol recall had been initiated due to consumer complaints of a musty scent coming from the containers.
Tylenol 8-Hour recall
Monday, more of the Tylenol recall had been announced. 128,000 bottles of 50-count Tylenol 8-Hour Caplets were taken back voluntarily by Johnson and Johnson’s McNeil Consumer Healthcare division. According to the New York Times, the recall had been begun by McNeil due to a “musty or moldy odor” within the Tylenol 8-Hour. This was a complaint with United States and Puerto Rico products. The Tylenol recalled had been made at the company’s troubled Fort Washington, PA, plant before the facility was closed in March. The cause of the recall is the exact same excuse for why there had been a Tylenol recall in January, June and July with products produced in Puerto Rico at the McNeil factory. They said a chemical used to treat wooden transport pallets that leached into the Tylenol probably brought on there to be a moldy smell.
Continued recalls from Tylenol
A congressional inquiry has been going into Johnson and Johnson. This is because there are various recalls just this year. CNN accounts that last November, five lots of 100-count Tylenol Arthritis Pain were recalled for a stench causing nausea, stomach pain, vomiting and diarrhea. All lots of the product were recalled later in Dec. The recall had been then expanded even further to non-prescription drugs causing smell and nausea with things for instance Tylenol and Motrin. Then in May, 50 children’s medicines were added to the recall. There were safety concerns and level of quality manage issues that caused this.
Work much better on the controls
The McNeil plant had been closed by Johnson and Johnson. This was done in April. According to Reuters, Johnson and Johnson is revamping all of the level of quality manage plans in the facility. This is so the violations found by the United States of America Food and drug administration can be fixed. The FDA found thick dust, grime and contaminated drug ingredients. Drugs manufactured at the Fort Washington plant contributed sales of about $650 million a year to Johnson and Johnson’s bottom line. The company will make about $600 billion less this year due to recalls and plant closings, claims Bloomberg.
Data from
New York Times
prescriptions.blogs.nytimes.com/2010/10/18/more-trouble-with-tylenol/?partner=rss and emc=rss
CNN
cnn.com/2010/HEALTH/10/19/tylenol.recall/index.html?npt=NP1
Reuters
reuters.com/article/idUSTRE69I2W320101019
No comments:
Post a Comment